The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furn Regulatory News (DFS)

Share Price Information for Dfs Furn (DFS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 114.00
Bid: 114.00
Ask: 115.20
Change: 1.00 (0.88%)
Spread: 1.20 (1.053%)
Open: 114.00
High: 115.60
Low: 114.00
Prev. Close: 113.00
DFS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 Jan 2024 07:00

RNS Number : 2118A
DFS Furniture PLC
19 January 2024
 

19 January 2024

 

Immediate release

 

DFS Furniture plc ("DFS" and the "Group")

 

Trading Update

 

Market share gains and cost base improvements mitigate challenging trading conditions

Full year profit guidance unchanged

 

DFS Furniture plc, the market leading retailer of living room and upholstered furniture in the United Kingdom, today announces a trading update for the twenty six week financial reporting period to 24 December 2023, together with an update on recent trading.

 

Summary:

? Group order intake down -1.1% on last year, outperforming a challenging market

? ?First half underlying profit before tax and brand amortisation (PBTu) expected to be up slightly year on year, supported by continued progress on gross margin and cost base improvements

? Full year guidance unchanged at £30-35m PBTu

 

Trading overview:

Overall market demand has been weaker than anticipated, down approximately -9%1 year on year in volume terms. We believe this performance was particularly impacted by record hot weather in September and early October when footfall and demand proved to be especially weak. We have since seen demand recover and our profit guidance assumes market volumes are down -5% year on year through the remainder of the second half.

 

Although we have not been immune to the market volatility and weaker demand, Group Order Intake for the period of -1.1% year on year was ahead of the market1.

 

Gross sales, recognised on delivery of orders to customers were down -5.6% / -£39m year on year. As expected, this was a greater decline than order intake as a result of the unwind of an elevated opening order bank at the start of the prior year resulting in a higher level of delivered sales in the comparator period.

 

Despite the tougher than expected market conditions, we expect to report PBTu for the first half slightly ahead of the prior year (FY23 £7.1m). This has been supported by improved operational performance, manufacturing & sourcing and cost to operate efficiency programmes.

 

Non underlying charges for the period are expected to be c£6m, with a c£4m cash cost. These relate to completing the planned closure of part of our manufacturing operations and implementation costs associated with our cost to operate efficiency programmes. Our full year expectation for non underlying charges of £7m (with a £5m cash cost) remains in line with previous guidance.

 

We expect to report closing net bank debt at the end of the period (excluding capitalised leases) of c£134m (FY23 year end £140m, facility size £250m) and leverage of c1.7x (FY23 year end 1.9x)2

 

Outlook:

 

Full year guidance

September 2023

January 2024

Revenue

£1,060m-£1,080m

£1,020m-£1,040m

PBTu

£30m-£35m

£30m-35m

Cash capex

£25m-£30m

£25-£30m

Non underlying costs (cash)

£4m-£5m

£5m

 

We have reduced our revenue guidance to reflect the weaker than expected demand. The impact of this reduction on PBT is expected to be offset by progress lowering our operating costs and our full year profit guidance remains unchanged at £30-35m PBTu (FY23 £30.6m).

 

Order intake for the winter sale campaign to date is consistent with our first half run rate. Our full year guidance assumes that Group order intake grows at low single digit levels across the second half partially supported by growth in the final quarter as we anniversary softer comparatives. In addition, we assume that events in the Red Sea are resolved such that customer orders are delivered in line with typical lead times close to our year end.

 

Looking beyond FY24 we believe the Group is well positioned to deliver strong shareholder returns. Our scale and trusted brands provide us a relative advantage and should allow us to maintain our trend of market share gains. This, together with our strategies to continue improving gross margin rate and the efficiency of our cost base, should drive improvement in profit levels. Given market volumes are over 20% below pre-pandemic levels, market recovery and our planned growth in the Home segment provide us with confidence in our 8% PBT target over the medium term.

 

The Group will announce its interim results for the period ending 24 December 2023 on 19 March 2024.

 

Comment from Tim Stacey, Group Chief Executive

"The Group has performed well in tough trading conditions. Despite the weaker than expected market, good operational performance and progress on gross margins and lowering our cost base have enabled us to deliver a profit for the first half that is slightly ahead of the prior year and we remain on track to deliver our full year profit target.

 

Looking forward, the Group has good growth prospects and is well positioned to drive attractive returns for shareholders, capitalising on market recovery as well as growing our Home offering and delivering our 8% PBT target."

 

1 Market value share growth based on proprietary Barclaycard data. Market volume covers July-November period (source: CACI banking data) and an estimate for December

2 Leverage: Ratio of period end net bank debt to cash EBITDA for the previous twelve months

 

Enquiries:

 

DFS (enquiries via Teneo)

Tim Stacey (Group CEO)

John Fallon (Group CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Teneo

James Macey-White

Jessica Reid

Ayo Sangobowale

+44 (0)20 7353 4200

85fs.dfs@teneo.com

 

About DFS Furniture plc

 

The Group is the clear market-leading retailer of living room furniture in the United Kingdom. Our Group purpose is to bring great design and comfort into every living room, in an affordable, responsible and sustainable manner. We operate an integrated physical and digital retail network of living room furniture showrooms and web sites in the United Kingdom and Republic of Ireland, trading through our leading brands, DFS and Sofology. We attract customers through our targeted and national marketing activities and our reputation for high quality products and service, breadth of product offer and favourable consumer financing options. We fulfil orders for our exclusive product ranges through our own UK finished goods factories, and through manufacturing partners located in the UK, Europe and Far East, and delivered with care through our expert final-mile delivery service "The Sofa Delivery Company Limited".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSDLFITLIS
Date   Source Headline
9th Apr 20247:00 amRNSPost 2023 AGM Shareholder Engagement - Update
8th Apr 20247:00 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSInterim Results
19th Jan 20247:00 amRNSTrading Statement
21st Dec 20233:40 pmRNSHolding(s) in Company
1st Dec 20233:36 pmRNSHolding(s) in Company
15th Nov 202312:36 pmRNSHolding(s) in Company
14th Nov 202312:12 pmRNSHolding(s) in Company
10th Nov 20233:26 pmRNSRESULTS OF AGM
7th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 202312:14 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSAnnual Financial Report
22nd Sep 202310:13 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSFY23 Preliminary Results
7th Sep 20237:00 amRNS£250M NEW CREDIT FACILITIES SIGNED
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSDirector Declaration
9th Jun 20237:00 amRNSDirectorate Change
8th Jun 202310:25 amRNSHolding(s) in Company
3rd May 20239:51 amRNSHolding(s) in Company
21st Apr 20231:54 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim Results
9th Feb 20237:00 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTrading Statement
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20222:04 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.